ロード中...

Xenopus‐derived glucagon‐like peptide‐1 and polyethylene‐glycosylated glucagon‐like peptide‐1 receptor agonists: long‐acting hypoglycaemic and insulinotropic activities with potential therapeutic utilities

BACKGROUND AND PURPOSE: Incretin‐based therapies based on glucagon‐like peptide‐1 (GLP‐1) receptor agonists are effective treatments of type 2 diabetes. Abundant research has focused on the development of long‐acting GLP‐1 receptor agonists. However, all GLP‐1 receptor agonists in clinical use or de...

詳細記述

保存先:
書誌詳細
出版年:Br J Pharmacol
主要な著者: Han, Jing, Fei, Yingying, Zhou, Feng, Chen, Xinyu, Zhang, Ying, Liu, Lin, Fu, Junjie
フォーマット: Artigo
言語:Inglês
出版事項: John Wiley and Sons Inc. 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5773971/
https://ncbi.nlm.nih.gov/pubmed/29171021
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14107
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!